Anti-tumor necrosis factor VNAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shock

被引:25
作者
Bojalil, Rafael [1 ,2 ]
Teresa Mata-Gonzalez, Maria [3 ]
Sanchez-Munoz, Fausto [1 ]
Yee, Yepci [1 ]
Argueta, Ivan [1 ]
Bolanos, Lucia [1 ]
Manuel Amezcua-Guerra, Luis [1 ]
Amanda Camacho-Villegas, Tanya [4 ,5 ]
Sanchez-Castrejon, Edna [5 ]
Jakob Garcia-Ubbelohde, Walter [3 ]
Fedorovish Licea-Navarro, Alexei [5 ]
Marquez-Velasco, Ricardo [1 ,6 ]
Fernando Paniagua-Solis, Jorge [3 ]
机构
[1] Inst Nacl Cardiol Ignacio Chavez, Dept Immunol, Mexico City, DF, Mexico
[2] Univ Autonoma Metropolitana Xochimilco, Dept Hlth Care, Mexico City, DF, Mexico
[3] Labs Silanes, Mexico City 03100, DF, Mexico
[4] Univ Autonoma Baja California, Marine Sci Fac, Ensenada, Baja California, Mexico
[5] CICESE, Marine Biotechnol Dept, Ensenada, Baja California, Mexico
[6] Univ Valle Mexico, Dept Hlth Sci, Mexico City, DF, Mexico
关键词
Endotoxic shock; Sepsis; Anti-TNF; (V)NAR; Inflammation; NITRIC-OXIDE SYNTHASE; ANTIBODY FRAGMENTS; FACTOR-ALPHA; INTERLEUKIN-10; CONTROLS; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; INTERFERON-GAMMA; GENE-EXPRESSION; CECAL LIGATION; SEPSIS;
D O I
10.1186/1471-2172-14-17
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In sepsis, tumor necrosis factor (TNF) is the key factor triggering respiratory burst, tissue injury and disseminated coagulation. Anti-TNF strategies based on monoclonal antibodies or F(ab')(2) fragments have been used in sepsis with contradictory results. Immunoglobulin new antigen receptors (IgNAR) are a unique subset of antibodies consisting of five constant ((C)NAR) and one variable domains ((V)NAR). (V)NAR domains are the smallest, naturally occurring, antibody-based immune recognition units, having potential use as therapy. Our aim was to explore the impact of an anti-TNF (V)NAR on survival in an experimental model of endotoxic shock. Also, mRNA expression and serum protein of several inflammatory molecules were measured. Results: Endotoxic shock was induced by lipopolysaccharide (LPS) in male Balb/c mice. Animals were treated with anti-TNF (V)NAR domains, F(ab')(2) antibody fragments, or saline solution 15 minutes before, 2 h and 24 h after lethal dose(100) (LD100) LPS administration. TNF blockade with either (V)NAR domains or F(ab')(2) fragments were associated with lower mortality (60% and 75%, respectively) compared to LD100. Challenge with LPS induced significant production of serum TNF and interleukins -10 and -6 at 3 h. After that, significant reduction of IL-6 at 24 h (vs 3 h) was shown only in the (V)NAR group. Nitrites level also increased in response to LPS. In liver, TNF and IL-10 mRNA expression showed a pro-inflammatory imbalance in response to LPS. Blocking TNF was associated with a shift towards an anti-inflammatory status; however, polarization was more pronounced in animals receiving F(ab')(2) fragments than in those with (V)NAR therapy. With regard to IL-6, gene expression was increased at 3 h in all groups. TNF blockade was associated with rapid and sustained suppression of IL-6 expression, even more evident in the (V)NAR group. Finally, expression of inducible-nitric oxide synthase (iNOS) increased in response to LPS at 3 h, but this was decreased at 24 h only in the anti-TNF (V)NAR group. Conclusions: Anti-TNF (V)NAR single domains improved survival in a murine model of endotoxic shock. Protection was associated with regulation in the TNF/IL-10 balance, attenuation of IL-6 and iNOS gene expression in the liver as well as decreased serum IL-6 concentration.
引用
收藏
页数:7
相关论文
共 41 条
[1]  
[Anonymous], 2001, Phage Display: A Laboratory Manual
[2]   TNF-α controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways [J].
Bekker, LG ;
Freeman, S ;
Murray, PJ ;
Ryffel, B ;
Kaplan, G .
JOURNAL OF IMMUNOLOGY, 2001, 166 (11) :6728-6734
[3]   INTERLEUKIN-10 IS A CENTRAL REGULATOR OF THE RESPONSE TO LPS IN MURINE MODELS OF ENDOTOXIC-SHOCK AND THE SHWARTZMAN REACTION BUT NOT ENDOTOXIN TOLERANCE [J].
BERG, DJ ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
MENON, S ;
DAVIDSON, N ;
GRUNIG, G ;
RENNICK, D .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2339-2347
[4]  
Cesaris P., 1998, J BIOL CHEM, V273, P7566
[5]   Efficient tumor targeting by single-domain antibody fragments of camels [J].
Cortez-Retamozo, V ;
Lauwereys, M ;
Gh, GH ;
Gobert, M ;
Conrath, K ;
Muyldermans, S ;
De Baetselier, P ;
Revets, H .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :456-462
[6]   Hepatic response to sepsis: Interaction between coagulation and inflammatory processes [J].
Dhainaut, JF ;
Marin, N ;
Mignon, A ;
Vinsonneau, C .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S42-S47
[7]   DIFFERENTIAL-EFFECTS OF MONOCLONAL-ANTIBODIES TO TUMOR-NECROSIS-FACTOR-ALPHA AND GAMMA-INTERFERON ON INDUCTION OF HEPATIC NITRIC-OXIDE SYNTHASE IN EXPERIMENTAL GRAM-NEGATIVE SEPSIS [J].
EVANS, T ;
CARPENTER, A ;
SILVA, A ;
COHEN, J .
INFECTION AND IMMUNITY, 1992, 60 (10) :4133-4139
[8]   Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide [J].
Fujii, E ;
Yoshioka, T ;
Ishida, H ;
Irie, K ;
Muraki, T .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :90-94
[9]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550
[10]   Structure of an IgNAR-AMA1 complex: Targeting a conserved hydrophobic cleft broadens malarial strain recognition [J].
Henderson, Kylie A. ;
Streltsov, Victor A. ;
Coley, Andrew M. ;
Dolezal, Olan ;
Hudson, Peter J. ;
Batchelor, Adrian H. ;
Gupta, Aditi ;
Bai, Tao ;
Murphy, Vincent J. ;
Anders, Robin F. ;
Foley, Michael ;
Nuttall, Stewart D. .
STRUCTURE, 2007, 15 (11) :1452-1466